Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities

References

• Boekhout T, Gueho E. Basidiomycetous yeasts. Pathogenic Fungi in Humans and Animals2nd ed, H. Howard Dexter. Marcel Dekker, New York 2003; 535–564
   Google Scholar
• De Hoog GS, Guarro J, Gené JL, et al. Atlas of Clinical Fungi2nd ed. Centraalbureau voor Schimmelcultures, Universitat Rovira i Virgili, Utrecht/Reus 2000; 132–133
   Google Scholar
• Ikeda R, Sugita T, Shinoda T. Serological relationship of Cryptococcus spp.: distribution of antigenic fators in Cryptococcus and intrapsecies diversity. J Clin Microbiol 2000; 38: 4021–4025
   PubMedGoogle Scholar
• Bauters TGM, Swinne D, Boekhout T, et al. Repeated isolation of Cryptococcus laurentii in the oropharynx despite treatment with fluconazole. Mycopathologia 2002; 153: 133–135
   PubMedGoogle Scholar
• Averbuch D, Boekhout T, Falk R, et al. Fungemia in a cancer patient caused by fluconazole resistant Cryptococcus laurentii. Med Mycol 2002; 40: 479–484
   PubMed Web of Science ®Google Scholar
• Kordossis T, Avlami A, Velegraki A, et al. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol 1998; 36: 335–339
   PubMed Web of Science ®Google Scholar
• Sugita T, Takashima M, Ikeda R, et al. Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates. J Clin Microbiol 2000; 38: 1468–1471
   PubMedGoogle Scholar
• Takashima M, Sugita T, Shinoda T, et al. Three new combinations from the Cryptococcus laurentii complex: Cryptococcus aureus, Cryptococcus carnescens and Cryptococcus peneaus. Int J Syst Evol Microbiol 2003; 53: 1187–1194
   PubMedGoogle Scholar
• Rimek D. First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia. J Clin Microbiol 2004; 42: 481–483
   PubMed Web of Science ®Google Scholar
• Tintelnot K, Lostert H. Isolation of Cryptococcus adeliensis from clinical samples and the environment in Germany. J Clin Microbiol 2005; 43: 1007
   PubMedGoogle Scholar
• Dromer F, Moulignier A, Dupont B, et al. Myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 1995; 9: 395–396
   PubMed Web of Science ®Google Scholar
• Available from < www.cbs.knaw.nl>
   Google Scholar
• Sugita T, Takashima M, Ikeda R, et al. Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions. Microbiol Immunol 2001; 45: 291–297
   PubMed Web of Science ®Google Scholar
• Adams ED, Cooper BH. Evaluation of a modified Wickerham medium for identifying medically important yeasts. Am J Med Technol 1974; 40: 377–388
   PubMedGoogle Scholar
• N J W Kreger-van Rij, (ed). The Yeasts: A Taxonomic Study, 3rd ed. Amsterdam: Elsevier Science Publishers BV, 1984.
   Google Scholar
• Kwon Chung, KJ, Bennett, JE. Medical Mycology. Philadelphia; Lea and Febinger, 1992: 819.
   Google Scholar
• Pal M, Onda C, Hasegawa A. Isolation of saprophytic Cryptococcus neoformans. Jpn J Vet Sci 1990; 52: 1171–1174
   PubMedGoogle Scholar
• Pal, M. Pulmonary mycosis in a pigeon handler due to Cryptococcus neoformans var. neoformans. 2nd International Conference on Cryptococcus and cryptococcosis. Milan(Italy), 1993. Abstracts, 119.
   Google Scholar
• Bolano A, Stinchi S, Preziosi R, et al. Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res 2001; 1: 221–224
   PubMed Web of Science ®Google Scholar
• Gupta AK, Boekhout T, Theelen B, et al. Identification and typing of Malassezia species by amplified fragment length polymorphism (AFLP) and sequence analysis of the internal transcribed spacer (ITS) and large subunit (LSU) regions of ribosomal DNA. J Clin Microbiol 2004; 42: 4253–4260
   PubMed Web of Science ®Google Scholar
• Ikeda R, Shinoda T, Fukazawa Y, et al. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 1982; 16: 22–29
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts. Approved Standard; Document M27-A 2nd ed;. Wayne, PA: National Committee for Laboratory Standards, 2002.
   Google Scholar
• Viviani MA, Esposto MC, Cogliati M, et al. Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?. J Chemother 2003; 15: 124–128
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Martin-Diez F, Cuenca-Estrella M, et al. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27-A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother 2000; 44: 400–404
   PubMedGoogle Scholar
• Lozano-Chiu M, Paetznick VL, Ghannoum MA, et al. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol 1998; 36: 2817–2822
   PubMed Web of Science ®Google Scholar
• Casadevall A, Mukherjee J, Devi SJ, et al. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 1992; 165: 1086–1093
   PubMed Web of Science ®Google Scholar
• Ellis HT, William WJ. Sporotrichoid lymphocutaneous infections: aetiology, diagnosis and therapy. Am Fam Physic 2001; 63: 326–332
   PubMedGoogle Scholar
• Ryncarz RE, Heasley EC, Babinchak TJ. The clinical spectrum of nodulary lymphangitis. Hosp Physic 1999; 9: 63–66
   Google Scholar
• Kostman JR, DiNubile MJ. Nodulary lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118: 883–888
   PubMedGoogle Scholar
• Wilson JW. Cutaneous (chancriform) syndrome in deep mycoses. Arch Dermatol 1963; 87: 121–125
   Google Scholar
• Rippon JW. Medical Mycology3rd ed. WB Saunders Company, Philadelphia 1988; 666
   Google Scholar
• Ng WF, Loo KT. Cutaneous cryptococcosis-primary versus secondary disease. Report of two cases with review of literature. Am J Dermatopathol 1994; 16: 227
   Google Scholar
• Neuville S, Dromer F, Morin O, et al. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 2003; 36: 337–347
   PubMedGoogle Scholar
• Narayan S, Batta K, Colloby P, et al. Cutaneous cryptococcosis infection due to C. albidus associated with Sezary syndrome. Br J Dermatol 2000; 143: 632–634
   PubMedGoogle Scholar
• Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol 2003; 41: 177–188
   PubMed Web of Science ®Google Scholar
• Ellis DH, Pfeiffer TJ. Ecology, life cycle and infectious propagules of Cryptococcus neoformans. Lancet 1990; 336: 923–925
   PubMed Web of Science ®Google Scholar
• Lazera MS, Pires FDA, Camillo-Coura L, et al. Natural habitat of Cryptococcus neoformans var.gattii in decaying wood forming hollows in living trees. J Vet Med Mycol 1996; 34: 127–131
   PubMedGoogle Scholar
• Lazera MS, Salmito MA, Londero AT, et al. Possible primary ecological niche of Cryptococcus neoformans. Med Mycol 2000; 38: 379–383
   PubMed Web of Science ®Google Scholar
• Fonseca A, Scorzetti G, Fell JW. Diversity in the yeast Cryptococcus albidus and related species revealed by ribosomal DNA sequence analysis. Can J Microbiol 2000; 46: 7–27
   PubMedGoogle Scholar
• Odds FC, De Backer T, Dams G, et al. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J Clin Microbiol 1995; 33: 995–997
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al. In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother 2004; 48: 3107–3111
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Ibrahim AS, Fu Y, et al. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol 1992; 30: 2881–2886
   PubMed Web of Science ®Google Scholar
• Witt MD, Lewis RJ, Larsen RA, et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 1996; 22: 322–328
   PubMed Web of Science ®Google Scholar
• Krajden S, Summerbell RC, Kane J, et al. Normally saprobic cryptococci isolated from Cryptococcus neoformans infections. J Clin Microbiol 1991; 29: 1883–1887
   PubMed Web of Science ®Google Scholar